These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9774902)

  • 1. [Risk factors for cervico-uterine cancer in women in Zacatecas].
    Castañeda-Iñiguez MS; Toledo-Cisneros R; Aguilera-Delgadillo M
    Salud Publica Mex; 1998; 40(4):330-8. PubMed ID: 9774902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic study of risk factors in cancer of the cervix uteri in Thai women.
    Punyaratabandhu P; Supanvanich S; Tirapat C; Podhipak A
    J Med Assoc Thai; 1982 May; 65(5):231-9. PubMed ID: 7119622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reproductive risk factors and sexual history associated with cervical cancer in Mexico].
    Lazcano-Ponce EC; Hernández-Avila M; López-Carrillo L; Alonso de Ruíz P; Torres-Lobatón A; González-Lira G; Romieu I
    Rev Invest Clin; 1995; 47(5):377-85. PubMed ID: 8584808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
    Hildesheim A; Herrero R; Castle PE; Wacholder S; Bratti MC; Sherman ME; Lorincz AT; Burk RD; Morales J; Rodriguez AC; Helgesen K; Alfaro M; Hutchinson M; Balmaceda I; Greenberg M; Schiffman M
    Br J Cancer; 2001 May; 84(9):1219-26. PubMed ID: 11336474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for invasive carcinoma of the uterine cervix in Latin America.
    Herrero R; Brinton LA; Reeves WC; Brenes MM; Tenorio F; de Britton RC; Gaitán E; Montalván P; García M; Rawls WE
    Bull Pan Am Health Organ; 1990; 24(3):263-83. PubMed ID: 2171706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reproductive risk factors and uterine cervix cancer in Mexico City].
    Lazcano-Ponce EC; Rojas-Martínez R; López-Acuńa MP; López-Carrillo L; Hernández-Avila M
    Salud Publica Mex; 1993; 35(1):65-73. PubMed ID: 8470022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for in situ cervical cancer: results from a case-control study.
    Jones CJ; Brinton LA; Hamman RF; Stolley PD; Lehman HF; Levine RS; Mallin K
    Cancer Res; 1990 Jun; 50(12):3657-62. PubMed ID: 2340514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiologic factors in cervical intraepithelial neoplasia III in our experience].
    Miranda Serrano P; Grande García J; Gómez Alvarez C; Granada Corrochano J
    Rev Esp Oncol; 1985; 32(4):657-70. PubMed ID: 3880162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocoagulation and the risk of cervical neoplasia.
    La Vecchia C; Franceschi S; Decarli A; Fasoli M; Gentile A; Gritti P
    Obstet Gynecol; 1985 Nov; 66(5):703-7. PubMed ID: 4058829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and cervical carcinoma in situ in Chile.
    Molina R; Thomas DB; Dabancens A; Lopez J; Ray RM; Martinez L; Salas O
    Cancer Res; 1988 Feb; 48(4):1011-5. PubMed ID: 3338072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria.
    Ogunbowale T; Lawoyin TO
    Aust J Rural Health; 2008 Dec; 16(6):338-42. PubMed ID: 19032205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An attempt to estimate the incidence of cervical dysplasia in a group of New Zealand women using contraception. The New Zealand Contraception and Health Study Group.
    Epidemiology; 1995 Mar; 6(2):121-6. PubMed ID: 7742396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral contraceptives on risk of cervical cancer.
    Vanakankovit N; Taneepanichskul S
    J Med Assoc Thai; 2008 Jan; 91(1):7-12. PubMed ID: 18386537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
    Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
    Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and cancer.
    Holck S; Ebeling K
    Arch Geschwulstforsch; 1986; 56(2):155-67. PubMed ID: 3518652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.